Local expression of secondary lymphoid tissue chemokine delivered by adeno-associated virus within the tumor bed stimulates strong anti-liver tumor immunity

Journal of Virology

Volumn 81, Issue 17, 2007, Pages 9502-9511

  Liang, Chun Min ^a   Zhong, Cui Ping ^a   Sun, Rui Xia ^a   Liu, Bin Bin ^a   Huang, Cheng ^a   Qin, Jie ^a   Zhou, Shuang ^a   Shan, Junling ^a   Liu, Yin Kun ^a   Ye, Sheng Long ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; CD3 ANTIGEN; CD9 ANTIGEN; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; DENDRITIC CELL; EFFECTOR CELL; FEMALE; GENE EXPRESSION; GENETIC CODE; IMMUNE RESPONSE; IMMUNITY; LIVER CELL CARCINOMA; LIVER TUMOR; LYMPHOID TISSUE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TARGET CELL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REGRESSION; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CARCINOMA, HEPATOCELLULAR; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; DENDRITIC CELLS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; T-LYMPHOCYTE SUBSETS; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; MURINAE; MUS MUSCULUS;

EID: 34548153716     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00208-07     Document Type: Article

References (58)

1. Baekkevold, E. S., T. Yamanaka, R. T. Palframan, H. S. Carlsen, F. P. Reinholt, U. H. von Andrian, P. Brandtzaeg, and G. Haraldsen. 2001. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. 193:1105-1112.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
3. Bartlett, J. S., R. Wilcher, and R. J. Samulski. 2000. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74:2777-2785.
4. Bjorklund, A., D. Kirik, C. Rosenblad, B. Georgievska, C. Lundberg, and R. J. Mandel. 2000. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res. 886:82-98.
5. Campbell, J. J., E. P. Bowman, K. Murphy, K. R. Youngman, M. A. Siani, D. A. Thompson, L.Wu, A. Zlotnik, and E. C. Butcher. 1998. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J. Cell Biol. 141:1053-1059.
6. Chan, V. W., S. Kothakota, M. C. Rohan, L. Panganiban-Lustan, J. P. Gardner, M. S. Wachowicz, J. A. Winter, and L. T. Williams. 1999. Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells. Blood 93:3610-3616.
7. Cukor, G., N. R. Blacklow, S. Kibrick, and I. C. Swan. 1975. Effect of adeno-associated virus on cancer expression by herpesvirus-transformed hamster cells. J. Natl. Cancer Inst. 55:957-959.
8. DeLisser, H. M., M. Christofidou-Solomidou, R. M. Strieter, M. D. Burdick, C. S. Robinson, R. S. Wexler, J. S. Kerr, C. Garlanda, J. R. Merwin, J. A. Madri, and S. M. Albelda. 1997. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am. J. Pathol. 151:671-677.
9. During, M. J., R. J. Samulski, J. D. Elsworth, M. G. Kaplitt, P. Leone, X. Xiao, J. Li, A. Freese, J. R. Taylor, R. H. Roth, J. R. Sladek, Jr., K. L. O'Malley, and D. E. Redmond, Jr. 1998. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther. 5:820-827.
10. Fan, L., C. R. Reilly, Y. Luo, M. E. Dorf, and D. Lo. 2000. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J. Immunol. 164:3955-3959.
11. Flanagan, K., D. Moroziewicz, H. Kwak, H. Horig, and H. L. Kaufman. 2004. The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells. Cell Immunol. 231:75-84.
12. Gunn, M. D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L. T. Williams, and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 289:451-460.
13. Gunn, M. D., K. Tangemann, C. T am, J. G. Cyster, S. D. Rosen, and L. T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95:258-263.
14. Hanson, H. L., D. L. Donermeyer, H. Ikeda, J. M. White, V. Shankaran, L. J. Old, H. Shiku, R. D. Schreiber, and P. M. Allen. 2000. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity 13:265-276.
15. Hermonat, P. L. 1994. Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer. Cancer Res. 54:2278-2281.
16. Hisada, M., T. Yoshimoto, S. Kamiya, Y. Magami, H. Miyaji, T. Yoneto, K. Tamada, T. Aoki, Y. Koyanagi, and J. Mizuguchi. 2004. Synergistic anti-tumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT. Cancer Gene Ther. 11:280-288.
17. Hromas, R., C. H. Kim, M. Klemsz, M. Krathwohl, K. Fife, S. Cooper, C. Schnizlein-Bick, and H. E. Broxmeyer. 1997. Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J. Immunol. 159:2554-2558.
18. Huang, A. Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961-965.
19. Jenh, C. H., M. A. Cox, H. Kaminski, M. Zhang, H. Byrnes, J. Fine, D. Lundell, C. C. Chou, S. K. Narula, and P. J. Zavodny. 1999. Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. J. Immunol. 162:3765-3769.
20. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
21. Kellermann, S. A., S. Hudak, E. R. Oldham, Y. J. Liu, and L. M. McEvoy. 1999. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J. Immunol. 162:3859-3864.
22. Kessler, P. D., G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne. 1996. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93:14082-14087.
23. Kim, C. H., L. M. Pelus, E. Appelbaum, K. Johanson, N. Anzai, and H. E. Broxmeyer. 1999. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. Cell Immunol. 193:226-235.
24. Kirk, C. J., D. Hartigan-O'Connor, B. J. Nickoloff, J. S. Chamberlain, M. Giedlin, L. Aukerman, and J. J. Mule. 2001. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Res. 61:2062-2070.
25. Lee, H. C., S. J. Kim, K. S. Kim, H. C. Shin, and J. W. Yoon. 2000. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 408:483-488.
26. Matsushita, T., S. Elliger, C. Elliger, G. Podsakoff, L. Villarreal, G. J. Kurtzman, Y. Iwaki, and P. Colosi. 1998. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 5:938-945.
27. Nagira, M., T. Imai, R. Yoshida, S. Takagi, M. Iwasaki, M. Baba, Y. Tabira, J. Akagi, H. Nomiyama, and O. Yoshie. 1998. A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells. Eur. J. Immunol. 28:1516-1523.
28. Nagira, M., T. Imai, K. Hieshima, J. Kusuda, M. Ridanpaa, S. Takagi, M. Nishimura, M. Kakizaki, H. Nomiyama, and O. Yoshie. 1997. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J. Biol. Chem. 272:19518-19524.
29. Nakai, H., E. Montini, S. Fuess, T. A. Storm, M. Grompe, and M. A. Kay. 2003. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34:297-302.
30. Nomura, T., H. Hasegawa, M. Kohno, M. Sasaki, and S. Fujita. 2001. Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-lα chemokine genes. Int. J. Cancer 91:597-606.
31. Ochsenbein, A. F., P. Klenerman, U. Karrer, B. Ludewig, M. Pericin, H. Hengartner, and R. M. Zinkernagel. 1999. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc. Natl. Acad. Sci. USA 96:2233-2238.
32. Ochsenbein, A. F., S. Sierro, B. Odermatt, M. Pericin, U. Karrer, J. Hermans, S. Hemmi, H. Hengartner, and R. M. Zinkernagel. 2001. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411:1058-1064.
33. Pachynski, R. K., S. W. Wu, M. D. Gunn, and D. J. Erie. 1998. Secondary lymphoid-tissue chemokine (SLC) stimulates integrin alpha 4 beta 7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) underflow. J. Immunol. 161:952-956.
34. Rohr, U. P., M. A. Wulf, S. Stahn, U. Steidl, R. Haas, and R. Kronenwett. 2002. Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J. Virol. Methods 106:81-88.
35. Saeki, H., A. Moore, M. Brown, and S. Hwang. 1999. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162:2472-2475.
36. Sanlioglu, S., P. Benson, and J. F. Engelhardt. 2000. Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation. Virology 268:68-78.
37. Sharma, S., M. Stolina, L. Zhu, Y. Lin, R. Batra, M. Huang, R. Strieter, and S. M. Dubinett. 2001. Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res. 61:6406-6412.
38. Sharma, S., M. Stolina, J. Luo, R. M. Strieter, M. Burdick, L. X. Zhu, R. K. Batra, and S. M. Dubinett. 2000. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. J. Immunol. 164: 4558-4563.
39. Sharma, S., S. C. Yang, S. Hillinger, L. X. Zhu, M. Huang, R. K. Batra, J. F. Lin, M. D. Burdick, R. M. Strieter, and S. M. Dubinett. 15 April 2003, posting date. SLC/CCL21-mediated anti-tumor responses require IFN-gamma, MIG/CXCL9 and IP-10/CXCL10. Mol. Cancer 2:22. doi:10.1186/1476-4598-2-22.
40. Solowiej, A., P. Biswas, D. G raesser, and J. A. Madri. 2003. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am. J. Pathol. 162:953-962.
41. Soto, H., W. Wang, R. M. Strieter, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, J. Hedrick, and A. Zlotnik. 1998. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. USA 95:8205-8210.
42. Su, H., S. Joho, Y. Huang, A. Barcena, J. Arakawa-Hoyt, W. Grossman, and Y. W. Kan. 2004. Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc. Natl. Acad. Sci. USA 101:16280-16285.
43. Suzuki, G., H. Sawa, Y. Kobayashi, Y. Nakata, K. Nakagawa, A. Uzawa, H. Sakiyama, S. Kakinuma, K. Iwabuchi, and K. Nagashima. 1999. Pertussis toxin-sensitive signal controls the trafficking of thymocytes across the corticomedullary junction in the thymus. J. Immunol. 162:5981-5985.
44. Tolba, K. A., W. J. Bowers, J. Muller, V. Housekneckt, R. E. Giuliano, H. J. Federoff, and J. D. Rosenblatt. 2002. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity. Cancer Res. 62:6545-6551.
45. Vicari, A. P., S. A. Yahia, K. Chemin, A. Mueller, A. Zlotnik, and C. Caux. 2000. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J. Immunol. 165:1992-2000.
46. Wang, Z., J. M. Allen, S. R. Riddell, P. Gregorevic, R. Storb, S. J. Tapscott, J. S. Chamberlain, and C. S. Kuhr. 2007. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Hum. Gene Ther. 18:18-26.
47. Warren, P., W. Song, E. Holle, L. Holmes, Y. Wei, J. Li, T. Wagner, and X. Yu. 2002. Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice. Anticancer Res. 22:599-604.
48. Weidner, N., J. P. Semple, and W. R. Welch. 1991. Tumor angiogenesis and metastasis 2 correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1-8.
49. Wick, M., P. Dubey, H. Koeppen, C. T. Siegel, P. E. Fields, L. Chen, J. A. Bluestone, and H. Schreiber. 1997. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J. Exp. Med. 186:229-238.
50. Willimann, K., D. F. Legler, M. Loetscher, R. S. Roos, M. B. Delgado, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1998. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur. J. Immunol. 28:2025-2034.
51. Wu, F. Y., C. Y. Wu, C. H. Lin, and C. H. Wu. 1999. Suppression of tumorigenicity in cervical carcinoma HeLa cells by an episomal form of adeno-associated virus. Int. J. Oncol. 15:101-106.
52. Xu, R., X. Sun, L. Y. Tse, H. Li, P. C. Chan, S. Xu, W. Xiao, H. F. Kung, G. W. Krissansen, and S. T. Fan. 2003. Long-term expression of angiostatin suppresses metastatic liver cancer in mice. Hepatology 37:1451-1460.
53. Yamano, T., Y. Kaneda, S. Huang, S. H. Hiramatsu, and D. S. Hoon. 2006. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant. Mol. Ther. 13:194-202.
54. Yang, S. C., R. K. Batra, S. Hillinger, K. L. Reckamp, R. M. Strieter, S. M. Dubinett, and S. Sharma. 2006. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res. 66:3205-3213.
55. Yang, S. C., S. Hillinger, K. Riedl, L. Zhang, L. Zhu, M. Huang, K. Atianzar, B. Y. Kuo, B. Gardner, R. K. Batra, R. M. Strieter, S. M. Dubinett, and S. Sharma. 2004. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Clin. Cancer Res. 10:2891-2901.
56. Yoshida, R., M. Nagira, M. Kitaura, N. Imagawa, T. Imai, and O. Yoshie. 1998. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J. Biol. Chem. 273:7118-7122.
57. Zhang, F., C. L. Chen, J. Q. Qian, J. T. Yan, K. Cianflone, X. Xiao, and D. W. Wang. 2005. Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase. Cell Res. 15:717-724.
58. Zhong, L., W. Li, Z. Yang, L. Chen, Y. Li, K. Qing, K. A. Weigel-Kelley, M. C. Yoder, W. Shou, and A. Srivastava. 2004. Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo. Gene Ther. 11:1165-1169.